Skip to main content
FinSpry Logo
FinSpry
ACAD logo
ACAD
(NASDAQ)
ACADIA Pharmaceuticals Inc.
$29.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ACADIA Pharmaceuticals (ACAD) Stock Price & Financial Analysis

ACADIA Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.21 - $29.03
52-Week High$29.85
52-Week Low$19.69
Open$28.63
Volume1.12M
Average Volume (3M)1.64M
Market Cap5.01B
Shares Outstanding172.71M
P/E Ratio (TTM)13.34
Forward P/E8.04
Price to Sales (P/S)4.57
Price to Book (P/B)4.01
EV/EBITDA40.47
Revenue (TTM)1.10B
Net Income (TTM)375.65M
Free Cash Flow (TTM)113.59M
EPS (TTM)$2.20
Profit Margin34.30%
Operating Margin7.39%
Return on Equity (ROE)30.10%
Debt to Equity0.04
50-Day MA$25.20
200-Day MA$24.02
52-Week Change14.53%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About ACADIA Pharmaceuticals

What is the current stock price for ACAD?

As of the latest trading session, ACAD stock trades at $29.01. The 52-week range is $19.69–$29.85, with a day range of $28.21–$29.03.

What is the P/E ratio for ACAD?

ACADIA Pharmaceuticals's trailing P/E ratio is 13.3, meaning investors pay $13.3 for every $1 of annual earnings. The forward P/E is 8.0, reflecting analyst expectations for future earnings. ACADIA Pharmaceuticals operates in the Healthcare sector.

Does ACAD pay dividends?

ACADIA Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ACAD?

Based on 9 analysts, the consensus for ACAD is Buy.

What is the market cap of ACAD?

ACADIA Pharmaceuticals's market capitalization is $5.01B, classifying it as a mid-cap company. ACADIA Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.